2025 China (Xiamen) International Life Sciences Exhibition

From May 27 to 29, 2025, the 2025 Xiamen International Life Sciences Exhibition will be held at the Xiamen International Convention and Exhibition Center, marking it as one of the largest life sciences events in Fujian Province. This exhibition is expected to draw over 800 companies from across the country, with an exhibition area exceeding 60,000 square meters. Organizers invite everyone to join this grand event, discussing the future of life sciences together.

The exhibition will focus on showcasing the latest products and technologies in the life sciences industry, including research reagents, cell biology, stem cell technology, vaccine development, and biopharmaceuticals. Exhibiting companies will have the opportunity to build brand recognition, promote trade collaborations, expand markets, and lead industry trends.

To further promote industry exchanges and cooperation, multiple technical forums, including the 'Senior Forum on Life Sciences Industry', will be held during the exhibition, inviting national and international experts and representatives for in-depth discussions. The forums will explore industry development trends and share successful experiences, providing new insights and driving force for the future of life sciences. The range of products on display is extensive, covering fields such as biotechnological instruments, analytical testing instruments, materials analysis instruments, and high-end medical devices.

Notably, this exhibition will bring together many cutting-edge biopharmaceutical technologies such as targeted drugs, gene editing, and stem cell and gene therapies, allowing industry professionals to gain a deep understanding of market demands and industry prospects. Additionally, the exhibition will showcase the application of big data and artificial intelligence in life sciences, fostering digital transformation and technological innovation.

We look forward to welcoming professional audiences to visit and engage in discussions, collectively contributing to the advancement of technology and market development in the life sciences industry.